Annual Report 2003 Aventis - Sanofi

More documents

Recommendations

Info

Your Contacts Your Contacts at <strong>Aventis</strong> <strong>Aventis</strong> 67917 Strasbourg Cedex 9 France Tel.: +33 (0) 388 99 1100 Fax: +33 (0) 388 99 1101 E-Mail: info@aventis.com www.aventis.com Communications Carsten Tilger Tel.: +33 (0) 388 99 1114 Fax: +33 (0) 388 99 1113 E-Mail: Carsten.Tilger@aventis.com Investor Relations Arvind Sood Tel.: +33 (0) 388 99 1246 Fax: +33 (0) 388 99 1375 E-Mail: Arvind.Sood@aventis.com Private Shareholder Relations Jacques Mazard Tel.: +33 (0) 388 99 1579 Fax: +33 (0) 388 99 1335 E-Mail: Jacques.Mazard@aventis.com >> 55
Dates & Publications Calendar of Events First-quarter results: April 29, 2004 Second-quarter results: July 29, 2004 Third-quarter results: October 28, 2004002 >> 56
Page 1 and 2:
Life can’t wait. Aventis 2003 Ann
Page 3 and 4:
Financial Highlights Net Sales (in
Page 5 and 6:
Therapeutic Area Key Developments R
Page 7 and 8:
Letter to Shareholders Dear Shareho
Page 9 and 10: Meeting Future Challenges >> 4
Page 11 and 12: Report of the Supervisory Board Dea
Page 13 and 14: 8
Page 16 and 17: 11
Page 18 and 19: Aventis Strategic Brands Taxotere (
Page 20: Expert Opinion on Oncology >> 15
Page 23 and 24: Medical Background Diabetes mellitu
Page 25 and 26: Production and Manufacturing Meetin
Page 28 and 29: 23
Page 30 and 31: Aventis Human Vaccines Pediatric co
Page 32: Expert Opinion on Immunization >> 2
Page 35 and 36: Medical Background Deep vein thromb
Page 37 and 38: Sales and Marketing The Power of Ev
Page 40 and 41: 35
Page 42 and 43: Aventis Strategic Brands Allegra /
Page 44 and 45: Expert Opinion on Infectious Diseas
Page 46 and 47: Targocid (teicoplanin) is a consist
Page 48 and 49: Key Regulatory Achievements in 2003
Page 50 and 51: program is designed to enable Avent
Page 52 and 53: Africa, we supplied 60 000 vials of
Page 54 and 55: Nutrition and Aventis CropScience i
Page 56 and 57: 51
Page 58 and 59: still constitute a signifi cant par
Page 62 and 63: Brand names appearing in italics th
show all

Annual Report 2003 Aventis - Sanofi

Create successful ePaper yourself

Delete template?

Save as template?